Revenue: The sum of all revenue fields included for a company's operating activities.
Entia Biosciences Inc. (ERGO) had Revenue of $0.27M for the most recently reported fiscal year, ending 2016-12-31.
| Income Statement Financials | |
|
Revenue |
$0.27M |
$-1.40M |
|
$0.09M |
|
$0.17M |
|
$1.58M |
|
$-1.31M |
|
$-0.09M |
|
$-1.40M |
|
$-1.40M |
|
$-1.40M |
|
$-1.40M |
|
$-1.40M |
|
$-1.40M |
|
$-1.31M |
|
$-1.22M |
|
28.14M |
|
28.14M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$0.23M |
|
$0.02M |
|
$0.20M |
|
$0.44M |
|
$2.11M |
|
$0.30M |
|
$0.30M |
|
$2.41M |
|
$-1.97M |
|
$-2.15M |
|
$-1.97M |
|
28.15M |
|
| Cash Flow Statement Financials | |
$-0.72M |
|
$-0.01M |
|
$0.77M |
|
$0.02M |
|
$0.08M |
|
$0.05M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-0.18 |
|
-0.53 |
|
65.53% |
|
-493.60% |
|
-493.60% |
|
-458.53% |
|
-525.79% |
|
-525.79% |
|
$-0.72M |
|
-- |
|
-- |
|
-- |
|
0.60 |
|
1.31 |
|
33.30 |
|
10.96 |
|
70.97% |
|
64.83% |
|
-317.84% |
|
83.76% |
|
$-0.07 |
|
$-0.03 |
|
$-0.03 |
|